The KIF13A Knockout A-549 Polyclonal Cells are a polyclonal population of CRISPR/Cas9-edited A-549 lung epithelial cells carrying a targeted disruption of the KIF13A gene. This gene disruption abrogates the expression of functional KIF13A, a plus-end-directed kinesin motor protein, generating a loss-of-function model. As polyclonal knockout cells, this population retains the cellular heterogeneity of the parental line while uniformly lacking KIF13A activity, making it suitable for population-level functional assays without clonal selection artifacts.
The parental A-549 cell line is an adherent, epithelial cell line established from a lung adenocarcinoma of a 58-year-old Caucasian male. It harbors a KRAS G12S mutation and is widely employed as a model system for non-small cell lung cancer (NSCLC). A-549 cells exhibit robust tumorigenic properties in vitro and in vivo, and they are extensively used to study oncogenic signaling, cancer cell migration, and drug responses.
KIF13A functions as a plus-end-directed kinesin motor that transports recycling endosomes along microtubules, enabling delivery of membrane cargo to the plasma membrane. Recruitment of KIF13A to endosomes is mediated by the active form of the small GTPase Arf6 (Arf6-GTP), and its activity is regulated by protein kinase D (PKD)-mediated phosphorylation. Upon activation, KIF13A promotes the translocation of recycling endosomes to the cell periphery, facilitating actin remodeling and Rac1-driven cell migration. Key molecular interactions include direct binding of KIF13A to Arf6, association with actin, and regulation by PKD. Thus, KIF13A couples Arf6 endocytic recycling to the actin cytoskeleton and migration machinery.
In the context of A-549 cells, KIF13A knockout provides a powerful tool to dissect the contribution of polarized recycling endosome trafficking to NSCLC progression. Given the KRAS G12S driver mutation and the established role of Arf6 signaling in cancer cell migration, disruption of KIF13A enables researchers to examine how endosomal transport modulates metastatic behavior. This model is particularly relevant for investigating the interplay between oncogenic KRAS signaling and cytoskeletal dynamics, as well as for evaluating the dependency of lung adenocarcinoma cells on kinesin-mediated receptor recycling during invasion.
Researchers can employ these polyclonal knockout cells in scratch wound healing assays and Boyden chamber invasion assays to quantify migration and invasion defects. Immunofluorescence microscopy for recycling endosome markers (e.g., Rab11) reveals altered endosomal distribution, and co-immunoprecipitation studies can assess KIF13A?CArf6 binding. Western blotting for phospho-PKD probes upstream signaling, and live-cell imaging captures vesicle transport dynamics. These cells are also suited for screening anti-metastatic compounds targeting the Arf6?CKIF13A?Cactin axis. For additional information, please contact Ascent Research.
